DIVIDEND ANNOUNCEMENT: Ultra Nasdaq Biotechnology/ProShares Trust (NASDAQ:BIB) on 09/22/2026 declared a dividend of $0.0826 per share

Ultra Nasdaq Biotechnology/ProShares Trust (NASDAQ:BIB) on 09/22/2026 declared a dividend of $ 0.0826 per share payable on September 29, 2026 to shareholders of record as of September 23, 2026. Dividend amount recorded is an increase of $ 0.0755 from last dividend Paid.

Ultra Nasdaq Biotechnology/ProShares Trust (NASDAQ:BIB) has paid dividends since 2010, has a current dividend yield of 0.2643793821% and has increased its dividends for 0 successive years.

Ultra Nasdaq Biotechnology/ProShares Trust's market cap is $ 215,599,270 and has a PE ratio of 0.00. The stock price closed yesterday at $ 113.47 and has a 52 week low/high of $ 55.34 and $ 126.40.

ProShares Ultra Nasdaq Biotechnology ETF (the "Fund") is an open-end management investment company. The Fund seeks daily investment results, before fees and expenses, that correspond to two times the inverse (?2x) of the daily performance of the NASDAQ Biotechnology Index® (the "Index"). The Index is a modified capitalization-weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark which also meet other eligibility criteria determined by NASDAQ. As of May 31 2013, the Fund's total assets were $112,166,575 and the Fund's investment portfolio was valued at $101,557,383.

For more information on Ultra Nasdaq Biotechnology/ProShares Trust click here.